Mild progressive multifocal leukoencephalopathy after switching from natalizumab to ocrelizumab

OBJECTIVE: To describe the disease course of carryover progressive multifocal leukoencephalopathy (PML) after switching from natalizumab to ocrelizumab in 2 patients with relapsing-remitting MS. METHODS: Two case reports with 1 year of follow-up and retrospective longitudinal measurements of serum n...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neurol Neuroimmunol Neuroinflamm
Main Authors: Toorop, Alyssa A., van Lierop, Zoë Y.G., Strijbis, Eva E.M., Teunissen, Charlotte E., Petzold, Axel, Wattjes, Mike P., Barkhof, Frederik, de Jong, Brigit A., van Kempen, Zoé L.E., Killestein, Joep
Formato: Artigo
Idioma:Inglês
Publicado: Lippincott Williams & Wilkins 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7577542/
https://ncbi.nlm.nih.gov/pubmed/33051344
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000904
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares